POU5F1 and bladder transitional cell carcinoma: Sedaghat et al. suggested that OCT4/CD133 can be efficiently used for early diagnosis and for determining the prognosis of patients with BLCA, but OCT4 and CD133 cannot be used as independent prognostic factors for BLCA [39].